Effects of Reducing the South and Reinforcing the North Method on Inflammatory Injury Induced by Hyperlipidemia

Table 2

The active component and key target of RSRN.

Compound	Type	Betweenness	Closeness	Degree	Eigenvector
Quercetin	Mol	6956.367	0.001616	426	0.172085
Kaempferol	Mol	1074.972	0.001422	114	0.093268
Stigmasterol	Mol	234.9962	0.001351	112	0.071736
Luteolin	Mol	966.566	0.001414	110	0.077567
Beta-sitosterol	Mol	188.0214	0.001361	88	0.076787
Anhydroicaritin	Mol	173.2552	0.001372	66	0.083024
Danshinone II A	Mol	1130.871	0.00122	41	0.073208
Dehydrotanshinone II A	Mol	26.81371	0.001348	40	0.06437
Palmatine	Mol	16.99011	0.001297	34	0.054885
C-homoerythrinan, 1,6-didehydro-3,15,16-trimethoxy-, (3. Beta.)-	Mol	292.7947	0.001333	32	0.070996
PTGS2	Gene	6853.524	0.001597	231	0.158477
PTGS1	Gene	1835.112	0.001504	148	0.126258
SCN5A	Gene	1382.629	0.001497	137	0.127246
HSP90AA1	Gene	2411.688	0.001497	131	0.107942
NCOA2	Gene	2395.628	0.001481	130	0.098189
ADRB2	Gene	1468.898	0.001495	127	0.12509